The Discounted Cash Flow (DCF) valuation of Genscript Biotech Corp (1548.HK) is (7.25) HKD. With the latest stock price at 17.21 HKD, the upside of Genscript Biotech Corp based on DCF is -142.2%.
Based on the latest price of 17.21 HKD and our DCF valuation, Genscript Biotech Corp (1548.HK) is a sell. selling 1548.HK stocks now will result in a potential gain of 142.2%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 8.3% - 13.2% | 10.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (17.75) - (3.82) | (7.25) |
| Upside | -203.2% - -122.2% | -142.2% |